Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
0.741
-0.018 (-2.33%)
Nov 21, 2024, 11:29 AM EST - Market open
Revelation Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -15.52 | -0.12 | -10.83 | -11.99 | -3.8 |
| Depreciation & Amortization | 0.03 | 0.03 | 0.03 | 0.02 | - |
| Stock-Based Compensation | 0.15 | 0.16 | 0.3 | 0.47 | 0.04 |
| Other Operating Activities | -0.15 | -8.33 | 0.01 | 0.05 | - |
| Change in Accounts Payable | 1.8 | 0.75 | -0.67 | -0.27 | 1.3 |
| Change in Other Net Operating Assets | -2.89 | 0.23 | -0.06 | 0.63 | 0.32 |
| Operating Cash Flow | -16.58 | -7.29 | -11.22 | -11.09 | -2.13 |
| Capital Expenditures | -0.04 | - | - | -0.13 | - |
| Investing Cash Flow | -0.04 | - | - | -0.13 | - |
| Short-Term Debt Issued | - | - | 2.5 | - | - |
| Total Debt Issued | - | - | 2.5 | - | - |
| Short-Term Debt Repaid | - | - | -2.5 | - | - |
| Long-Term Debt Repaid | - | - | -0.8 | - | - |
| Total Debt Repaid | - | - | -3.3 | - | - |
| Net Debt Issued (Repaid) | - | - | -0.8 | - | - |
| Issuance of Common Stock | 9.16 | 14.03 | 11.72 | 0.6 | 8.26 |
| Repurchase of Common Stock | - | - | -7.65 | - | - |
| Other Financing Activities | - | - | 11.92 | - | - |
| Financing Cash Flow | 9.16 | 14.03 | 15.2 | 8 | 8.87 |
| Net Cash Flow | -7.45 | 6.74 | 3.98 | -3.22 | 6.74 |
| Free Cash Flow | -16.61 | -7.29 | -11.22 | -11.22 | -2.13 |
| Free Cash Flow Per Share | -11.70 | -31.87 | -154.57 | - | - |
| Levered Free Cash Flow | -6.5 | -4.11 | -3.66 | -6.71 | - |
| Unlevered Free Cash Flow | -6.5 | -4.11 | -3.66 | -6.71 | - |
| Change in Net Working Capital | 1.3 | -1.12 | -2.8 | -0.41 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.